0001181431-14-024975.txt : 20140627
0001181431-14-024975.hdr.sgml : 20140627
20140625160325
ACCESSION NUMBER: 0001181431-14-024975
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140623
FILED AS OF DATE: 20140625
DATE AS OF CHANGE: 20140625
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly James M
CENTRAL INDEX KEY: 0001560782
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 14940046
MAIL ADDRESS:
STREET 1: INCYTE CORPORATION EXPERIMENTAL STATION
STREET 2: RTE 141 & HENRY CLAY RD. BLDG E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
4
1
rrd412255.xml
X0306
4
2014-06-23
0
0000879169
INCYTE CORP
INCY
0001560782
Daly James M
EXPERIMENTAL STATION
ROUTE 141 AND HENRY CLAY RD
WILMINGTON
DE
19880
0
1
0
0
EVP, Chief Commercial Officer
Common Stock
2014-06-23
4
M
0
2777
18.32
A
2777
D
Common Stock
2014-06-23
4
S
0
2777
56.38
D
0
D
Common Stock
2014-06-23
4
M
0
7832
16.62
A
7832
D
Common Stock
2014-06-23
4
M
0
502
16.62
A
8334
D
Common Stock
2014-06-23
4
S
0
8334
55.92
D
0
D
Non-Qualified Stock Option (right to buy)
18.32
2014-06-23
4
M
0
2777
0
D
2020-02-08
Common Stock
2777
50099
D
Non-Qualified Stock Option (right to buy)
16.62
2014-06-23
4
M
0
7832
0
D
2019-10-21
Common Stock
7832
124311
D
Incentive Stock Option (right to buy)
16.62
2014-06-23
4
M
0
502
0
D
2019-10-21
Common Stock
502
9024
D
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning October 22, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Represents weighted average sale price. Actual sales prices ranged from $56.12-$56.87.
Represents weighted average sale price. Actual sales prices ranged from $55.67-$56.29.
/s/ James M. Daly
2014-06-25